Terence O’Reilly
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer
- Sphingolipid Metabolism and Signaling
- Angiogenesis and VEGF in Cancer
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 9
- Angiogenesis and VEGF in Cancer 4
- Oncology 11
- Cancer Treatment and Pharmacology 6
- HER2/EGFR in Cancer Research 3
- Co-authors
- Heidi A. Lane (12 shared papers)Anne Boulay (7 shared papers)Paul M.J. McSheehy (8 shared papers)Jeanette M. Wood (8 shared papers)Markus Wartmann (7 shared papers)Sabine Zumstein-Mecker (5 shared papers)George Thomas (4 shared papers)Peter R. Allegrini (8 shared papers)
- Journals
- Cancer Research (7 papers)Clinical Cancer Research (5 papers)Cancer Chemotherapy and Pharmacology (3 papers)Radiology (2 papers)Translational Oncology (2 papers)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Terence O’Reilly
38 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 115
- Oncology 958
- Molecular Biology 1.8k
- Cancer Research 351
- Cell Biology 327
- Genetics 187
Countries citing papers authored by Terence O’Reilly
This map shows the geographic impact of Terence O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terence O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terence O’Reilly more than expected).
Fields of papers citing papers by Terence O’Reilly
This network shows the impact of papers produced by Terence O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terence O’Reilly. The network helps show where Terence O’Reilly may publish in the future.
Co-authors
The 25 scholars most cited alongside Terence O’Reilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 436 | |
| 2 | 2004 | 285 | |
| 3 | 2005 | 285 | |
| 4 | 2001 | 280 | |
| 5 | 2006 | 249 | |
| 6 | 2009 | 197 | |
| 7 | 2008 | 176 | |
| 8 | 2000 | 169 | |
| 9 | 2008 | 148 | |
| 10 | 1999 | 128 | |
| 11 | 2006 | 116 | |
| 12 | 2010 | 110 | |
| 13 | 2010 | 88 | |
| 14 | 2005 | 72 | |
| 15 | 2002 | 66 | |
| 16 | 2008 | 64 | |
| 17 | 2005 | 60 | |
| 18 | 2009 | 57 | |
| 19 | 2005 | 42 | |
| 20 | 2000 | 34 |
About Terence O’Reilly
Terence O’Reilly is a scholar working on Molecular Biology, Oncology, Pharmacology, Cell Biology and Cancer Research, having authored 40 papers that have together received 3.3k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (9 papers), Cancer Treatment and Pharmacology (6 papers), Angiogenesis and VEGF in Cancer (4 papers), Microtubule and mitosis dynamics (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Renal cell carcinoma treatment (2 papers) and Bacterial Infections and Vaccines (2 papers). The work is most often cited by research in Oncology (958 citations), Molecular Biology (1.8k citations), Cancer Research (351 citations), Cell Biology (327 citations) and Genetics (187 citations). Terence O’Reilly has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Heidi A. Lane, Anne Boulay, Paul M.J. McSheehy, Jeanette M. Wood, Markus Wartmann, Sabine Zumstein-Mecker, George Thomas, Peter R. Allegrini, Karl‐Heinz Altmann and Christian Schnell. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Radiology and Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.